[12] [1] As an IMP, its storage and handling are governed by Good Clinical Practice (GCP) guidelines, EU/UK GMP Annex 13 (Investigational Medicinal Products), and the specific trial protocol not by a publicly available regulatory document
Several critical factors including real-world adherence, cost barriers, uncertainty surrounding widespread payer coverage, higher study dosages compared to real-world use, and gastrointestinal side effects affecting treatment tolerance, still remain questionable.
8- Glutathione and Intestinal Health: A significant decrease in the enzyme that provides glutathione synthesis and a low level of cysteine amino acids were determined in IBS (Irritable Bowel Syndrome) patients
Kariko, K., Muramatsu, H., Ludwig, J
Lovelle explains that glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone crucial for regulating blood sugar, appetite, and insulin secretion. Synthetic versions like semaglutide and tirzepatide have demonstrated remarkable efficacy
However, clinical observations suggest that injection may lead to better outcomes, even for gastrointestinal issues